SCHEMBL15030868

SCHEMBL15030868

c1ccc(-n2c3ccccc3c3cc(-c4ccc5c(c4)C4(c6ccccc6Sc6ccccc64)c4ccccc4N5c4ccc5c6ccccc6n(-c6ccccc6)c5c4)ccc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HDAC4 P56524 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15030698 0.87 KDM4E (0.35) KDM4EATML3MBTL1HDAC4
SCHEMBL25061399 0.86 L3MBTL1 (0.42) KDM4EATML3MBTL1HDAC4
SCHEMBL17197573 0.86 L3MBTL1 (0.42) KDM4EATML3MBTL1HDAC4
SCHEMBL25061381 0.86 L3MBTL1 (0.42) KDM4EATML3MBTL1HDAC4
SCHEMBL17197574 0.86 L3MBTL1 (0.42) KDM4EATML3MBTL1HDAC4
SCHEMBL21037677 0.86 KDM4E (0.38) KDM4EATML3MBTL1HDAC4
SCHEMBL21453931 0.84 L3MBTL1 (0.46) KDM4EATML3MBTL1HDAC4
SCHEMBL19977868 0.84 KDM4E (0.38) KDM4EATML3MBTL1
SCHEMBL19977902 0.84 KDM4E (0.38) KDM4EATML3MBTL1
SCHEMBL17482966 0.83 L3MBTL1 (0.43) KDM4EATML3MBTL1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10305040-B2 Spiro dihydroacridine derivatives and the use thereof as materials for organic electroluminescence devices MERCK PATENT GMBH (DE) 2019-05-28 US disclosed
EP-2780325-B1 SPIRO-DIHYDROACRIDINE DERIVATIVES AND THEIR USE AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2016-02-03 EP disclosed
US-20140316134-A1 SPIRO DIHYDROACRIDINE DERIVATIVES AND THE USE THEREOF AS MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2014-10-23 US disclosed
US-20140316134-A1 SPIRO DIHYDROACRIDINE DERIVATIVES AND THE USE THEREOF AS MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2014-10-23 US disclosed
WO-2013083216-A1 SPIRO DIHYDROACRIDINE DERIVATIVES AND THE USE THEREOF AS MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2013-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10305040-B2 Spiro dihydroacridine derivatives and the use thereof as materials for organic electroluminescence devices SORD, ALDH1A1, SDHA KDM4E 3566/4885ATM 2441/4885L3MBTL1 4454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.